Evaluation of the efficacy and safety of initial high-dose romiplostim for primary immune thrombocytopenia in the acute care setting
用户2AvsC3Tu4pD0
1个月前
58
10
已完结
1. 系统已在2026-01-19 17:00:54对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1097/MBC.0000000000001397
文献链接: https://journals.lww.com/10.1097/MBC.0000000000001397
其他信息:
出版社: Ovid Technologies (Wolters Kluwer Health)
作者: Grace Bringhurst; P. Christopher Parish; Hang Zeng; Danielle Boselli; Joseph B. Elmes; Donald C. Moore; Justin R. Arnall
